Medtronic Is Downgraded. Citi Says Harder to ‘Support the Stock.’

Medtronic


stock was downgraded to Neutral from Buy by analysts at Citi, who raised concern about the company’s ability to deliver consistent revenue growth.

Medtronic


(ticker: MDT) posted its second-quarter earnings Tuesday. Revenue came in at $7.59 billion, while Wall Street analysts had expected $7.7 billion.